Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mie K Jakobsen"'
Autor:
Per Guldberg, Tina M Green, Henrik J Ditzel, Morten F Gjerstorff, Fredrik B Thorén, Sofie Traynor, Mie K Jakobsen, Hana Komic, Yaseelan Palarasah, Christina B Pedersen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Cancer/testis antigens (CTAs) are widely expressed in melanoma and lung cancer, emerging as promising targets for vaccination strategies and T-cell-based therapies in these malignancies. Despite recognizing the essential impact of intratumoral hetero
Externí odkaz:
https://doaj.org/article/7b33650554d84d9abe5f3303d625a0d1
Autor:
Mie K. Jakobsen, Sofie Traynor, Mette Stæhr, Pascal G. Duijf, Aaraby Y. Nielsen, Mikkel G. Terp, Christina B. Pedersen, Per Guldberg, Henrik J. Ditzel, Morten F. Gjerstorff
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Identification of novel tumor-specific targets is important for the future development of immunotherapeutic strategies using genetically engineered T cells or vaccines. In this study, we characterized the expression of VCX2, a member of the VCX/Y can
Externí odkaz:
https://doaj.org/article/eadc291dbc1d42ceb12df8174478db8c
Autor:
Mie K. Jakobsen, Morten F. Gjerstorff
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/7ad17115edd04bc6a85c22ebd1e3ad25
Autor:
Mie K, Jakobsen, Sofie, Traynor, Mette, Stæhr, Pascal G, Duijf, Aaraby Y, Nielsen, Mikkel G, Terp, Christina B, Pedersen, Per, Guldberg, Henrik J, Ditzel, Morten F, Gjerstorff
Publikováno v:
Frontiers in Oncology
Identification of novel tumor-specific targets is important for the future development of immunotherapeutic strategies using genetically engineered T cells or vaccines. In this study, we characterized the expression of VCX2, a member of the VCX/Y can